MyFinsight
Home
Blog
About
Contact
Download
Download image
Product sales, net
$20,183K
(4.23%↑ Y/Y)
Income (loss) from
operations
$3,372K
(143.93%↑ Y/Y)
Total operating
expenses
$16,811K
(-37.83%↓ Y/Y)
Research and
development, net
-$3,447K
Gain on change in
accounting estimates on...
$1,933K
Income (loss) before
income tax expense
$393K
(104.44%↑ Y/Y)
Total other expense,
net
-$2,979K
(-151.60%↓ Y/Y)
Interest income
$15K
(-6.25%↓ Y/Y)
Selling and marketing
$9,682K
(5.51%↑ Y/Y)
General and
administrative
$7,393K
(-36.07%↓ Y/Y)
Cost of goods sold
$4,617K
(20.42%↑ Y/Y)
Amortization of intangible
asset
$499K
(-19.39%↓ Y/Y)
Net income (loss)
$391K
(104.41%↑ Y/Y)
Income tax expense
$2K
Other expense, net
$2,635K
(2.33%↑ Y/Y)
Change in fair value of
financial instruments
-$359K
(-109.71%↓ Y/Y)
Net income (loss)
attributable to common...
$274K
(103.06%↑ Y/Y)
Convertible preferred stock
deemed dividends
$117K
(211.43%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. (EVFM)